Contents
Academy · Research Promotion · Patient Education for Medicines
How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing
The 2003 National Assessment of Adult Literacy, whose report was published in 2006, examined literacy among US adults and found that approximately 30 million US adults have difficulty with basic reading tasks and only 12% have proficient health literacy. This finding defines the baseline against which all medicine-related patient content should be written.
Patient education content for a medicine is written material (a leaflet, a medication guide, a web page or an app screen) that explains to a non-specialist what a drug is for, how to take it and what to watch for, with the specific aim of changing or supporting what the patient does. This aim distinguishes it from prescribing information written for clinicians: the criterion of success is not technical completeness but whether an ordinary reader, often reading under stress, fatigue or anxiety, can locate the one instruction they need and act on it correctly. Two independent, government-level evidence bases, the US National Assessment of Adult Literacy and the health communication guidance of the Centers for Disease Control and Prevention (CDC), converge on the same finding: most patient materials are written well above the level that most patients can use, and the gap is large enough to constitute a design problem to be addressed deliberately rather than a detail to be refined at the end.
Learning objectives
- The findings of the National Assessment of Adult Literacy on health literacy in the United States, and their implications for the target reading level
- The drafting techniques (plain language, chunking and teach-back) recommended by published health-literacy guidance
- The ways in which regulatory requirements for medicine leaflets (FDA, EMA) reinforce the same plain-language standard
Common misconceptions
- “An accurate and complete patient leaflet has fulfilled its purpose.” The health-literacy guidance of the CDC (Centers for Disease Control and Prevention) states that comprehension levels are often two or more grades below a person’s reading or education level, and separately reports that only 12% of US adults have proficient health literacy; a technically accurate leaflet written at a typical 10th- to 12th-grade level is therefore likely to be unusable for most of its readers.
Health literacy gap addressed by patient content
The most widely cited baseline for US health literacy comes from the 2003 National Assessment of Adult Literacy, published by the National Center for Education Statistics in 2006, which measured health literacy directly across a nationally representative sample of adults9. The CDC’s current health-communication guide, Simply Put, summarizes the practical implication of that survey: an estimated 30 million US adults struggle with basic reading tasks, only 12% of consumers have proficient health literacy skills, and approximately one-third of US adults have difficulty reading and acting on health-related information1. The same guide makes an important point: comprehension levels are often two or more grades below a person’s general reading or education level, because unfamiliar medical vocabulary, stress and unfamiliar formatting all reduce effective comprehension below an individual’s baseline reading ability1. This compounding effect explains why a leaflet that reads easily to its author, almost always someone with years of specialist training, can still be functionally unreadable to the patient taking the medicine, irrespective of that patient’s level of education.
Drafting techniques for addressing the literacy gap
Published health-literacy guidance converges on a small set of concrete techniques rather than a general instruction to “simplify.” Weiss’s manual for clinicians, developed for the American Medical Association Foundation, recommends writing at or below a sixth-grade reading level, using short sentences and everyday words in place of medical terminology, relying on the active voice, and organizing content into small, clearly labeled chunks rather than dense paragraphs2. Doak, Doak, and Root’s classic text on teaching patients with low literacy skills adds that limiting each sentence to one idea, and each section to one main message, reduces the cognitive load on a reader who is trying to extract an actionable instruction, and recommends testing draft material with a validated readability formula such as SMOG before finalizing it3. These formulas have a long, independently verifiable history: Flesch’s 1948 formula and the later Flesch-Kincaid grade-level adaptation, developed originally for Navy technical manuals, both convert sentence length and syllable counts into an estimated US school grade level, providing writers with an objective target rather than a subjective impression of simplicity78. The CDC’s guidance adds formatting advice that readability formulas alone do not capture: using ample white space, limiting each page to one key action, and placing the most important instruction (what to do, not only what the medicine is) at the top rather than after background explanation1.
Regulatory requirements for readability testing
Medicines regulators have independently adopted the same standard from the opposite direction, by regulating the output rather than the drafting process. In the European Union, the guideline on the readability of the label and package leaflet requires marketing authorization holders to user-test the readability of a leaflet with patients before it can be approved, rather than relying on an expert’s judgement that the text is clear4. A review of the practical challenges of implementing this EU user-testing requirement documents how often a leaflet that appears clear to its drafting team still fails a structured comprehension test with users; plain-language techniques and formal readability formulas are designed to close precisely this gap before testing rather than after a failed test10. In the United States, the 2023 proposed rule of the Food and Drug Administration (FDA) on Medication Guides takes the same direction, aiming to consolidate several existing, inconsistently formatted patient-labeling documents into a single standardized Patient Medication Information document designed to be easier for patients to read and use5. Neither regulator treats plain language as a stylistic preference; both treat it as a testable requirement that a document must meet.
Verification of comprehension before publication
Writing to a target grade level is necessary but not sufficient, because a readability formula measures sentence and word complexity, not whether a reader extracted the intended instruction. The Health Literacy Universal Precautions Toolkit of the Agency for Healthcare Research and Quality (AHRQ) recommends the teach-back method as the direct check: the patient is asked to state in their own words what they understand they are supposed to do, which reveals the difference between a document that merely scores well on a formula and one that conveys the instruction6. For content that will be distributed to a large population rather than explained individually, the equivalent step is structured readability testing with a sample of intended readers before publication, the same principle that EU regulators formally require for package leaflets4. Incorporating this test into the content workflow, rather than treating a plain-language review as the final step, distinguishes patient education content that is demonstrably usable from content that merely appears simple to its authors.
Common errors in plain-language drafting
Even a draft that passes a readability-formula check can fail in practice for reasons the formula does not capture. One common error is simplifying vocabulary while leaving the structure of the document unchanged, so that a leaflet still opens with background on the condition or the mechanism of the drug before reaching the one instruction the patient needs; the actionable content is then obscured by preliminary material, irrespective of sentence-level simplicity1. A second common error is treating numeracy as equivalent to literacy: Doak, Doak, and Root note that many patients who read adequately still have difficulty with numeric concepts such as converting a dosing schedule into a daily routine or interpreting a percentage risk, so dosing instructions benefit from concrete, calendar-based phrasing (“take one tablet every morning with breakfast”) rather than abstract numeric instructions alone3. A third is translating content for non-English speakers directly from an already complex English source rather than first redrafting it in plain language and translating the simplified version; direct translation tends to carry the complexity of the original into the translated text. A fourth, and perhaps the most easily overlooked, is omitting the comprehension check because the content has already undergone a plain-language review; a plain-language review and a comprehension check answer different questions, and treating the first as a substitute for the second is precisely the gap that the guidance of the CDC and EU regulators is designed to close14. A fifth, broader error is treating the plain-language draft as a one-time deliverable rather than a document to be revisited whenever the underlying prescribing information changes; a dosing instruction, warning or contraindication updated in the clinician-facing label but not carried into the patient-facing content creates a direct safety gap, and AHRQ’s toolkit recommends building a routine cross-check between label updates and patient-material updates into the same regulatory change-control process that already tracks the clinician-facing label, rather than leaving that synchronization to chance6. Assigning a specific, named owner to this synchronization step, rather than leaving it as an implicit responsibility shared across regulatory affairs, medical writing and patient communications teams, is a simple organizational measure that addresses what several of the sources cited in this article identify as a recurring, preventable cause of outdated patient materials remaining in circulation after the clinical label has been revised.
Key points
Key points
Patient education content for a medicine must be written for a population in which only about 12% have proficient health literacy, and plain-language drafting techniques together with teach-back or formal readability testing are the means of confirming that the content meets this requirement rather than merely appearing simple to its author.
Practical application
Practical application
- Draft to a specific, measurable target rather than a general impression of simplicity. The target should be a sixth-grade reading level or below, assessed with a recognised formula such as SMOG or Flesch-Kincaid, and the score should be treated as a pass or fail criterion before the draft proceeds.
- Begin with the principal action the patient must take. The most important instruction should precede background explanation, and each section or page should be limited to one key message.
- Test comprehension directly in addition to readability. Teach-back with a small number of intended readers, or formal user testing for leaflets distributed to a large population, should be used, and the content revised according to the points readers could not restate accurately.
Frequently asked questions
Published health-literacy guidance generally recommends sixth-grade level or below, since the CDC and AMA Foundation materials both document that a large share of the population cannot reliably use material written above that level.
No. A formula measures sentence and word complexity, not comprehension. AHRQ’s teach-back method and the EU’s mandatory user testing for package leaflets both exist because a text can score well on a formula and still fail to convey the intended instruction to its readers.
Both. The EU's readability guideline makes user testing a condition of marketing authorization for package leaflets, and FDA's 2023 proposed rule on Medication Guides is explicitly designed to standardize and simplify US patient medication information, so this is an enforceable requirement in at least some jurisdictions, not only a voluntary best practice.
No. Simplifying language and chunking content concern how information is expressed and organized, not what is included; the same safety content can be conveyed in short sentences and everyday words without omission.
Prescribing information is written for a clinical audience and judged on technical completeness; patient education content is judged on whether a non-specialist reader, often under stress, can find and correctly act on the instruction that matters to them.
References
- Centers for Disease Control and Prevention. Simply Put: A Guide for Creating Easy-to-Understand Materials. read 10 October 2026. View on cdc.gov
- Weiss BD. Health Literacy and Patient Safety: Help Patients Understand. 2nd ed. American Medical Association Foundation and American Medical Association; 2007. read 10 October 2026. View on psnet.ahrq.gov
- Doak CC, Doak LG, Root JH. Teaching Patients with Low Literacy Skills. 2nd ed. J.B. Lippincott; 1996. read 10 October 2026. View via Harvard Chan School of Public Health
- European Commission. Guideline on the readability of the label and package leaflet of medicinal products for human use. 2009. read 10 October 2026. View on health.ec.europa.eu
- US Food and Drug Administration. Medication Guides: Patient Medication Information; Proposed Rule. Federal Register. 2023;88:36910. read 10 October 2026. View on federalregister.gov
- Agency for Healthcare Research and Quality. Health Literacy Universal Precautions Toolkit, 3rd Edition. read 10 October 2026. View on ahrq.gov
- Flesch R. A new readability formula. Journal of Applied Psychology. 1948;32(3):221-233. read 10 October 2026. View on APA PsycNet
- Kincaid JP, Fishburne RP, Rogers RL, Chissom BS. Derivation of New Readability Formulas for Navy Enlisted Personnel. Research Branch Report 8-75. 1975. read 10 October 2026. View on apps.dtic.mil
- Kutner M, Greenberg E, Jin Y, Paulsen C. The Health Literacy of America's Adults: Results From the 2003 National Assessment of Adult Literacy. NCES 2006-483. US Department of Education; 2006. read 10 October 2026. View on nces.ed.gov
- Pires C, Vigário M, Cavaco A. The Challenges for EU User Testing Policies for Patient Information Leaflets. read 10 October 2026. View on PMC
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing. Pubrica. https://pubrica.com/academy/medical-and-scientific-communication/write-patient-education-content-medicines/
Pubrica Academy. “How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing.” Pubrica, 10 Oct. 2026, pubrica.com/academy/medical-and-scientific-communication/write-patient-education-content-medicines/.
Pubrica Academy (2026) How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing. Pubrica. Available at: https://pubrica.com/academy/medical-and-scientific-communication/write-patient-education-content-medicines/ (Accessed: 15 October 2026).
Pubrica Academy. “How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing.” Pubrica. October 10, 2026. https://pubrica.com/academy/medical-and-scientific-communication/write-patient-education-content-medicines/
Pubrica Academy, ‘How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/medical-and-scientific-communication/write-patient-education-content-medicines/> accessed 15 October 2026.
Pubrica Academy. How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/medical-and-scientific-communication/write-patient-education-content-medicines/
Pubrica Academy, “How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/medical-and-scientific-communication/write-patient-education-content-medicines/
@misc{/la_patient_education_content_medicines_2026,
author = {{Pubrica Academy}},
title = {How to Write Patient Education Content for Medicines: Health Literacy, Plain Language and Readability Testing},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/medical-and-scientific-communication/write-patient-education-content-medicines/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Patient Content Readability Checklist
A checklist to apply to every patient-facing medicine document before release.
[ ] Checked grade level with a readability formula (target: 6th grade or below) [ ] Led with the single most important action, ahead of background explanation [ ] Replaced medical jargon with everyday words throughout [ ] Chunked content into short sections, one idea per sentence, one message per section [ ] Tested comprehension with teach-back or formal user testing on real intended readers [ ] Confirmed no safety content was cut while simplifying language
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s patient communications team drafts medicine-related patient education content to a measured readability target and conducts comprehension checks before publication, so that usability is verified rather than assumed from simplified wording.